OREXIGEN THERAPEUTICS INC's ticker is and the CUSIP is 686164AB0. A total of 20 filers reported holding OREXIGEN THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $547,000 | -26.2% | 2,066,000 | 0.0% | 0.06% | -37.9% |
| Q2 2016 | $741,000 | -10.0% | 2,066,000 | 0.0% | 0.10% | -28.6% |
| Q1 2016 | $823,000 | -32.0% | 2,066,000 | 0.0% | 0.13% | -42.2% |
| Q4 2015 | $1,210,000 | -15.5% | 2,066,000 | 0.0% | 0.23% | -38.3% |
| Q3 2015 | $1,432,000 | -25.9% | 2,066,000 | 0.0% | 0.37% | +10.0% |
| Q2 2015 | $1,933,000 | – | 2,066,000 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 10,000,000 | $5,025,000 | 0.78% |
| GLG LLC | 4,960,000 | $2,480,000 | 0.15% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 7,500,000 | $3,000,000,000 | 0.05% |